Cardenas M, Compton S, Caceres CJ, García-Sastre A. MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses. Nat Commun. 2026 Feb 10
Influenza A viruses (FLUAV) utilize sialic acid to enter host cells via the envelope´s hemagglutinin (HA), and its affinity for host-specific sialic acid linkage configuration is a major host range determinant. However, some FLUAV subtypes (H17, H18, H19) use the major histocompatibility complex class II (MHCII) as an entry receptor instead of sialic acid (SA), challenging our knowledge about FLUAV tropism and interspecies transmission potential. Here, we show that H3N2 viruses can use MHCII as an alternative entry receptor in a host-specific manner, and adaptation of human viruses to pigs increases affinity for the MHCII swine leukocyte antigen (SLA). By using two prototypic human-seasonal (hVIC/11) and swine-adapted (sOH/04) H3N2 viruses we found that expression of the human (HLA) but not the swine MHCII conferred replication of hVIC/11 in desialylated, non-susceptible cells. Further, expression of SLA in non-susceptible cells conferred susceptibility to infection by sOH/04. Introduction of point mutations near the hVIC/11 HA receptor-binding site (RBS) allowed the use of both human and swine MHCII. Our findings revealed that MHCII can serve as a sialic acid-independent entry receptor to H3N2 FLUAV in a host-specific manner, with potential implications for the viral pathogenesis and adaptation to a new species.
See Also:
Latest articles in those days:
- Real-time digital prescriptions unlock influenza dynamics: evidence from 21 million transactions 2 hours ago
- A single mutation in nonstructural protein 1 is critical for the adaptive evolution of influenza B virus 23 hours ago
- Fatal human H3N8 influenza virus has a moderate pandemic risk 23 hours ago
- No evidence of influenza A virus infection in marine mammals stranded in Basque Country coast (Northern Spain) in the context of H5N1 clade 2.3.4.4b expansion 23 hours ago
- Antibodies Elicited by the 2025-2026 Influenza Vaccine 23 hours ago
[Go Top] [Close Window]


